Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 1, 2009, Pages 358-363

  Resch, Hemma ^a   Karl, Katharina ^a   Weigert, Günther ^a   Wolzt, Michael ^a   Hommer, Anton ^a   Schmetterer, Leopold ^a   Garhöfer, Gerhard ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; ANTIHYPERTENSIVE AGENT; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; SULFONAMIDE;

AGED; ARTERY DILATATION; ARTICLE; BLOOD FLOW; CHOROID; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER FLOWMETRY; ERYTHROCYTE; FEMALE; HEMODYNAMICS; HUMAN; LASER DOPPLER FLOWMETRY; MALE; OCULAR BLOOD VESSEL; OPEN ANGLE GLAUCOMA; OPTIC NERVE; PRIORITY JOURNAL; RETINA BLOOD VESSEL; BLOOD FLOW VELOCITY; DRUG ANTAGONISM; INTRAOCULAR PRESSURE; OPTIC DISK; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION;

ADMINISTRATION, ORAL; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD FLOW VELOCITY; CHOROID; ERYTHROCYTES; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LASER-DOPPLER FLOWMETRY; MALE; OPTIC DISK; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; REGIONAL BLOOD FLOW; RETINAL VESSELS; SULFONAMIDES;

EID: 58249088275     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2460     Document Type: Article

References (34)

1. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007;114:1965-1972.
2. Flammer J, Orgul S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21:359-393.
3. Flammer J, Pache M, Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res. 2001;20:319-349.
4. Polak K, Luksch A, Frank B, Jandrasits K, Polska E, Schmetterer L. Regulation of human retinal blood flow by endothelin-1. Exp Eye Res. 2003;76:633-640.
5. Polak K, Petternel V, Luksch A, et al. Effect of endothelin and BQ123 on ocular blood flow parameters in healthy subjects. Invest Ophthalmol Vis Sci. 2001;42:2949-2956.
6. Orgul S, Cioffi GA, Wilson DJ, Bacon DR, Van Buskirk EM. An endothelin-1 induced model of optic nerve ischemia in the rabbit. Invest Ophthalmol Vis Sci. 1996;37:1860-1869.
7. Chauhan BC, LeVatte TL, Jollimore CA, et al. Model of endothelin-1-induced chronic optic neuropathy in rat. Invest Ophthalmol Vis Sci. 2004;45:144-152.
8. Cioffi GA, Orgul S, Onda E, Bacon DR, Van Buskirk EM. An in vivo model of chronic optic nerve ischemia: the dose-dependent effects of endothelin-1 on the optic nerve microvasculature. Curr Eye Res. 1995;14:1147-1153.
9. Noske W, Hensen J, Wiederholt M. Endothelin-like immunoreactivity in aqueous humor of patients with primary open-angle glaucoma and cataract. Graefes Arch Clin Exp Ophthalmol. 1997;235: 551-552.
10. Sugiyama T, Moriya S, Oku H, Azuma I. Association of endothelin-1 with normal tension glaucoma: clinical and fundamental studies. Surv Ophthalmol. 1995;39(suppl 1):S49 -S56.
11. Kaiser HJ, Flammer J, Wenk M, Luscher T. Endothelin-1 plasma levels in normal-tension glaucoma: abnormal response to postural changes. Graefes Arch Clin Exp Ophthalmol. 1995;233: 484 - 488.
12. Keltner JL, Johnson CA, Cello KE, et al. Classification of visual field abnormalities in the ocular hypertension treatment study. Arch Ophthalmol. 2003;121:643-650.
13. Weber C, Schmitt R, Birnboeck H, et al. Multiple-dose pharmacokinetics, safety, and tolerability of bosentan, an endothelin receptor antagonist, in healthy male volunteers. J Clin Pharmacol. 1999;39:703-714.
14. Polak K, Dorner GT, Kiss B, et al. Evaluation of the Zeiss retinal vessel analyser. Br J Ophthalmol. 2000;84:1285-1290.
15. Riva CE, Grunwald JE, Sinclair SH, Petrig BL. Blood velocity and volumetric flow rate in human retinal vessels. Invest Ophthalmol Vis Sci. 1985;26:1124-1132.
16. Riva CE, Grunwald JE, Sinclair SH, O'Keefe K. Fundus camera based retinal LDV. Appl Opt. 1981;20:117-120.
17. Riva CE, Harino S, Petrig BL, Shonat RD. Laser Doppler flowmetry in the optic nerve. Exp Eye Res. 1992;55;499-506.
18. Riva CE, Cranstoun SD, Grunwald JE, Petrig BL. Choroidal blood flow in the foveal region of the human ocular fundus. Invest Ophthalmol Vis Sci. 1994;35:4273-4281.
19. Bonner R, Nossal R. Principles of laser-Doppler flowmetry. In: Shepard AP, Öberg PA, ed. Developments in Cardiovascular Medicine: Laser Doppler Blood Flowmetry. Boston: Kluwer Academic Publishers; 1990:17-45.
20. Fuchsjager-Mayrl G, Luksch A, Malec M, Polska E, Wolzt M, Schmetterer L. Role of endothelin-1 in choroidal blood flow regulation during isometric exercise in healthy humans. Invest Ophthalmol Vis Sci. 2003;44:728-733.
21. Kirkby NS, Hadoke PW, Bagnall AJ, Webb DJ. The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house? Br J Pharmacol. 2008;153:1105-1119.
22. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev. 1994;46:325-415.
23. Ivy D, McMurtry IF, Yanagisawa M, et al. Endothelin B receptor deficiency potentiates ET-1 and hypoxic pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol. 2001;280:L1040-L1048.
24. de Juan JA, Moya FJ, Fernandez-Cruz A, Fernandez-Durango R. Identification of endothelin receptor subtypes in rat retina using subtype-selective ligands. Brain Res. 1995;690:25-33.
25. White LR, Bakken IJ, Sjaavaag I, Elsas T, Vincent MB, Edvinsson L. Vasoactivity mediated by endothelin ETA and ETB receptors in isolated porcine ophthalmic artery. Acta Physiol Scand. 1996;157: 245-252.
26. Kiel JW. Endothelin modulation of choroidal blood flow in the rabbit. Exp Eye Res. 2000;71:543-550.
27. Chakravarthy U, Douglas AJ, Bailie JR, McKibben B, Archer DB. Immunoreactive endothelin distribution in ocular tissues. Invest Ophthalmol Vis Sci. 1994;35:2448-2454.
28. Miyauchi T, Yanagisawa M, Iida K, et al. Age- and sex-related variation of plasma endothelin-1 concentration in normal and hypertensive subjects. Am Heart J. 1992;123:1092-1093.
29. Luksch A, Lasta M, Polak K, et al. Twelve hour reproducibility of retinal and optic nerve head blood flow parameters in healthy subjects. Acta Ophthalmol Scand. In press.
30. Polska E, Polak K, Luksch A, et al. Twelve hour reproducibility of choroidal blood flow parameters in healthy subjects. Br J Ophthalmol. 2004;88:533-537.
31. Yorio T, Krishnamoorthy R, Prasanna G. Endothelin: is it a contributor to glaucoma pathophysiology? J Glaucoma. 2002;11:259-270.
32. Prasanna G, Krishnamoorthy R, Clark AF, Wordinger RJ, Yorio T. Human optic nerve head astrocytes as a target for endothelin-1. Invest Ophthalmol Vis Sci. 2002;43:2704-2713.
33. Stokely ME, Brady ST, Yorio T. Effects of endothelin-1 on components of anterograde axonal transport in optic nerve. Invest Ophthalmol Vis Sci. 2002;43:3223-3230.
34. Rao VR, Krishnamoorthy RR, Yorio T. Endothelin-1 mediated regulation of extracellular matrix collagens in cells of human lamina cribrosa. Exp Eye Res. 2008;86:886-894.